Reliability of self-reported nicotine use as determined by serum cotinine levels in patients referred for liver transplantation

Psychosomatics

Volumn 51, Issue 5, 2010, Pages 395-400

  Bright, Robert P ^a   Civalier, Kari Martin ^a   Krahn, Lois ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE;

ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; INTERVIEW; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NICOTINE REPLACEMENT THERAPY; PATIENT REFERRAL; RELIABILITY; SELF REPORT;

EID: 77957360791     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1176/appi.psy.51.5.395     Document Type: Article

References (31)

1. National Center for Chronic Disease Prevention and Health Promotion: Health Effects of Cigarette Smoking. Centers for Disease Control and Prevention Fact Sheet. Dec. 2008
2. Herrero JI, Lorenzo M, Quiroga J, et al: De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 2005; 11:89-97 (Pubitemid 40124447)
3. Vallejo GH, Romero CJ, de Vicente JC: Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol 2005; 56:87-99
4. Pungpapong S, Manzarbeitia C, Ortiz J, et al: Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transpl 2002; 8:588-590
5. McConathy K, Turner V, Johnston T, et al: Analysis of smoking in patients referred for liver transplantation and its adverse impact on short-term outcomes. J KY Med Assoc 2007; 105:261-266
6. Ehlers SL, Rodrigue JR, Widows MR, et al: Tobacco use before and after liver transplantation: a single-center survey and implications for clinical practice and research. Liver Transpl 2004; 10:412-417
7. Attebring M, Herlitz J, Berndt AK, et al: Are patients truthful about their smoking habits? a validation of self-report about smoking cessation with biochemical markers of smoking activity amongst patients with ischaemic heart disease J Intern Med 2001; 249:145-151
8. Woodward M, Tunstall-Pedoe H: Biochemical evidence of persistent heavy smoking after a coronary diagnosis despite selfreported reduction: analysis from the Scottish Heart Health Study. Eur Heart J 1992; 13:160-165
9. Archbold GPR, Cupples ME, McKnight A, et al: Measurements of markers of tobacco smoking in patients with coronary heart disease. Ann Clin Biochem 1995; 32:201-207
10. van Berkel TFM, Boersma H, De Baquer D, et al: Registration and management of smoking behaviour in patients with coronary heart disease. Eur Heart J 1999; 20:1630-1637
11. Benowitz NL, Perez-Stable EJ, Fong I, et al: Ethnic differences in N-gucuronidation of nicotine and cotinine. J Pharmacol Exp Ther 1999; 291:1196-1203
12. Benowitz NL HJ, Hukkanen J, Jacob P 3rd: Nicotine chemistry, metabolism, kinetics, and biomarkers. Handb Exp Pharmacol 2009; 192:29-60
13. Dempsey D, Jacob PI, Benowitz NL: Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002; 301:594-598 (Pubitemid 34429972)
14. Benowitz NL, Jacob PI, Denaro C, et al: Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Ther 1991; 49:270-277
15. Benowitz NL, Jacob PI: Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994; 34:483-493
16. SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research 2002; 4:149-159
17. Lee PN: Misclassification of smoking habits and passive smoking. Int Arch Occup Environ Health (Supp. 99-925483-2). Berlin, Germany, Springer-Verlag, 1988
18. Altman DG, Bland JM: Statistics Notes: Diagnostic tests 2: predictive values. BMJ 1994; 309:102
19. McGinn TWP, Newman TB, Keitz S, et al: Tips for learners of evidence-based medicine 3: measures of observer variability (κ statistic). CMAJ 2004; 171:1369-1373 (Pubitemid 39573841)
20. Altman D (ed.): Practical Statistics for Medical Research. London, UK, Chapman & Hall, 1991
21. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, et al: Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987; 77:1435-1438 (Pubitemid 18011591)
22. Gilbert DD: Chemical analyses as validators in smoking cessation programs. J Behav Med 1993; 16:295-307
23. Nakajima M, Yokoi T: Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. Drug Metab 2005; 20:227-235
24. Nakajima M, Iwata K, Yamamoto T, et al: Nicotine metabolism in liver microsomes from rats with acute hepatitis or cirrhosis. Drug Metab Dispos 1998; 26:36-41 (Pubitemid 28071322)
25. Pasanen M, Rannala Z, Tooming A, et al: Hepatitis A impairs the function of human hepatic CYP2A6 in vivo. Toxicology 1997; 123:177-184 (Pubitemid 27443389)
26. Kratz F: Coumarin-7-hydroxylase activity in microsomes from needle biopsies of normal and diseased human liver. Eur J Clin Pharmacol 1976; 10:133-137
27. Langmann P, Bienert A, Zilly M, et al: Influence of smoking on cotinine and caffeine plasma levels in patients with alcoholic liver cirrhosis. Eur J Med Res 2000; 5:217-221
28. DiMartini A, Javed L, Russell S, et al: Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl 2005; 11:606-609 (Pubitemid 40872907)
29. Lee DS, Mathur AK, Acker WB 2nd, et al: Effects of smoking on survival for patients with end-stage liver disease. J Am Coll Surg 2009; 208:1077-1084
30. Sung RS, Althoen M, Howell TA, et al: Excess risk of renal allograft loss associated with cigarette smoking. Transplantation 2001; 71:1752-1757 (Pubitemid 32622486)
31. Leithead JA, Ferguson JW, Hayes PC: Smoking-related morbidity and mortality following liver transplantation. Liver Transplantation 2008; 14:1159-1164